European Malaria Vaccine Initiative

The European Vaccine Initiative (EVI) is a leading European non-profit Product Development Partnership (PDP) dedicated to developing effective and affordable vaccines against diseases of poverty and emerging infectious diseases. Established in 1998 as the European Malaria Vaccine Initiative (EMVI), the organization transitioned to its current name in 2009 to reflect a broader scope beyond malaria. EVI acts as a catalyst by providing strategic advisory services, project management, and funding coordination to move vaccine candidates from the laboratory into clinical trials. The organization manages a diverse portfolio of vaccine candidates, collaborating with academic institutions, pharmaceutical companies, and global health organizations. EVI is headquartered in Germany and receives support from various European governments and international foundations.